Human interferon-lambda3 is a potent member of the type III interferon family - PubMed (original) (raw)
Human interferon-lambda3 is a potent member of the type III interferon family
C Dellgren et al. Genes Immun. 2009 Mar.
Abstract
Type III interferon (IFN) or IFN-lambda is a recently discovered family of IFNs that signal through the same downstream transcription factors as type I IFN but use a separate receptor complex composed of the IL-10R2 and the unique IFN-lambdaR1 receptor chains. We have established a simple and efficient expression system to produce highly pure and active IFN-lambda of the three human IFN-lambda isoforms (IFN-lambda1, -lambda2 and -lambda3) and used this to compare the biological activity of the different IFN-lambda subtypes. Surprisingly, we found IFN-lambda3 to possess the highest specific activity of the human IFN-lambda subtypes, exhibiting a twofold higher activity than IFN-lambda1 and a 16-fold higher activity than IFN-lambda2. Furthermore, in comparison with the commercially available preparations of IFN-lambda1 and -lambda2, we found our IFN-lambda preparation to be superior in activity.
Similar articles
- A novel method for detection of IFN-lambda 3 binding to cells for quantifying IFN-lambda receptor expression.
Santer DM, Minty GES, Mohamed A, Baldwin L, Bhat R, Joyce M, Egli A, Tyrrell DLJ, Houghton M. Santer DM, et al. J Immunol Methods. 2017 Jun;445:15-22. doi: 10.1016/j.jim.2017.03.001. Epub 2017 Mar 6. J Immunol Methods. 2017. PMID: 28274837 - Antiviral activity of bovine type III interferon against bovine viral diarrhea virus is greatly reduced in bovine turbinate cells due to limited expression of IFN lambda receptor 1 (IL-28Rα).
Dassanayake RP, Menghwar H, Bickel KA, Holthausen DJ, Ma H, Diaz-San Segunda F, Rodriguez-Calzada M, Medina GN, Attreed S, Falkenberg SM, Kanipe C, Sacco RE, De Los Santos T, Casas E. Dassanayake RP, et al. Front Immunol. 2024 Aug 19;15:1441908. doi: 10.3389/fimmu.2024.1441908. eCollection 2024. Front Immunol. 2024. PMID: 39224597 Free PMC article. - The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain.
Donnelly RP, Sheikh F, Kotenko SV, Dickensheets H. Donnelly RP, et al. J Leukoc Biol. 2004 Aug;76(2):314-21. doi: 10.1189/jlb.0204117. Epub 2004 May 3. J Leukoc Biol. 2004. PMID: 15123776 Review. - Induction of an antiviral state and attenuated coxsackievirus replication in type III interferon-treated primary human pancreatic islets.
Lind K, Richardson SJ, Leete P, Morgan NG, Korsgren O, Flodström-Tullberg M. Lind K, et al. J Virol. 2013 Jul;87(13):7646-54. doi: 10.1128/JVI.03431-12. Epub 2013 May 1. J Virol. 2013. PMID: 23637411 Free PMC article. - Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses.
Li M, Liu X, Zhou Y, Su SB. Li M, et al. J Leukoc Biol. 2009 Jul;86(1):23-32. doi: 10.1189/jlb.1208761. Epub 2009 Apr 30. J Leukoc Biol. 2009. PMID: 19304895 Review.
Cited by
- Interferon-λ: Immune Functions at Barrier Surfaces and Beyond.
Lazear HM, Nice TJ, Diamond MS. Lazear HM, et al. Immunity. 2015 Jul 21;43(1):15-28. doi: 10.1016/j.immuni.2015.07.001. Immunity. 2015. PMID: 26200010 Free PMC article. Review. - Ex vivo induction of IFN-λ3 by a TLR7 agonist determines response to Peg-IFN/ribavirin therapy in chronic hepatitis C patients.
Murata K, Sugiyama M, Kimura T, Yoshio S, Kanto T, Kirikae I, Saito H, Aoki Y, Hiramine S, Matsui T, Ito K, Korenaga M, Imamura M, Masaki N, Mizokami M. Murata K, et al. J Gastroenterol. 2014 Jan;49(1):126-37. doi: 10.1007/s00535-013-0814-1. Epub 2013 Apr 17. J Gastroenterol. 2014. PMID: 23591768 Free PMC article. - The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity.
Mendoza JL, Schneider WM, Hoffmann HH, Vercauteren K, Jude KM, Xiong A, Moraga I, Horton TM, Glenn JS, de Jong YP, Rice CM, Garcia KC. Mendoza JL, et al. Immunity. 2017 Mar 21;46(3):379-392. doi: 10.1016/j.immuni.2017.02.017. Immunity. 2017. PMID: 28329704 Free PMC article. - Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines.
Melchjorsen J. Melchjorsen J. Viruses. 2013 Jan 31;5(2):470-527. doi: 10.3390/v5020470. Viruses. 2013. PMID: 23435233 Free PMC article. Review. - Type I and Type III Interferons Differ in Their Adjuvant Activities for Influenza Vaccines.
Ye L, Ohnemus A, Ong LC, Gad HH, Hartmann R, Lycke N, Staeheli P. Ye L, et al. J Virol. 2019 Nov 13;93(23):e01262-19. doi: 10.1128/JVI.01262-19. Print 2019 Dec 1. J Virol. 2019. PMID: 31511392 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources